Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press Series of Journals Center for Evidence-Based and Translational Medicine of Wuhan University

The title
  • The title
  • The keywords
  • The author
Submit
Home Articles Vol 35,2026 No.1 Detail

Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (13): advances in the application and case studies of systematic review and Meta-analysis

Published on Jan. 28, 2026Total Views: 92 times Total Downloads: 27 times Download Mobile

Author: DIAO Sha 1, 2, 3, 4 HU Yuanhui 1, 2, 3, 4, 5 LIU Jianing 1, 2, 3, 4, 5, 6 LI Hailong 1, 2, 3, 4 ZOU Kun 1, 2, 3, 4 YANG Chunsong 1, 2, 3, 4 BO Zhenyan 1, 2, 3, 4 WEI Yuanxiu 1, 2, 3, 4 YANG Jiayi 1, 2, 3, 4 ZENG Linan 1, 2, 3, 4, 7 ZHANG Lingli 1, 2, 3, 4, 7, 8

Affiliation: 1. Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China 2. Children's Medicine Key Laboratory of Sichuan Province, Chengdu 610041, China 3. NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation, Chengdu 610041, China 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, China 5. West China School of Pharmacy, Sichuan University, Chengdu 610041, China 6. West China School of Medicine, Sichuan University, Chengdu 610041, China 7. West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu 610041, China 8. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China

Keywords: Pharmacoepidemiology Methodology Guidelines Systematic review Meta-analysis

DOI: 10.12173/j.issn.1005-0698.202512034

Reference: DIAO Sha, HU Yuanhui, LIU Jianing, LI Hailong, ZOU Kun, YANG Chunsong, BO Zhenyan, WEI Yuanxiu, YANG Jiayi, ZENG Linan, ZHANG Lingli. Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (13): advances in the application and case studies of systematic review and Meta-analysis[J]. Yaowu Liuxingbingxue Zazhi, 2026, 35(1): 2-16. DOI: 10.12173/j.issn.1005-0698.202512034.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

As a pivotal study design in pharmacoepidemiology, systematic review and Meta-analysis could provide core evidence to support drug evaluations. The Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) categorizes systematic review and Meta-analysis as two specific types of secondary research, outlines the application scenarios of Meta-analysis and network Meta-analysis in comparative drug efficacy research, and introduces the use of artificial intelligence in the literature screening phase of systematic review. Building upon the Guide (2nd edition), we further elaborate on the advances in the application of systematic review and Meta-analysis from three dimensions: the expansion of evaluation scope, innovations in synthesis methodology, and the transformation of intelligent paradigms. Finally, taking network Meta-analysis as an example, we illustrate its implementation process in pharmacoepidemiological research. The objective of this article is to provide methodological references for researchers conducting systematic review and Meta-analysis in the field of pharmacoepidemiology.

Full-text
Please download the PDF version to read the full text: download
References

1.李幼平, 刘雪梅. 系统评价的起源、发展和作用[J]. 中国循证医学杂志, 2011, 11(1): 2-6. [Li YP, Liu XM. History, progress and role of systematic review[J]. Chinese Journal of Evidence-Based Medicine, 2011, 11(1): 2-6.] DOI: 10.3969/j.issn.1672-2531.2011.01.002.

2.Egger M, Smith GD, Altman DG. Systematic reviews in health care: Meta-analysis in context[M]. London: BMJ Books, 2001: 1-16.

3.Cumpston M, Flemyng E, Thomas J, et al. Chapter l: Introduction[EB/OL]. (2023-08) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter-ionlinepdfv65.

4.Smith MC, Naftel DC. Meta-analysis: a perspective for research synthesis[J]. Image J Nurs Sch, 1984, 16(1): 9-13. DOI: 10.1111/j.1547-5069.1984.tb01375.x.

5.Glass GV. Primary, secondary, and Meta-analysis of research[J]. Educ Researcher, 1976, 5: 3-8. DOI: 10.3102/0013189X0050 10003.

6.Thacker SB. Meta-analysis: a quantitative approach to research integration[J]. JAMA, 1988, 259(11): 1685-1689. DOI: 10.1001/jama.259.11.1685.

7.张伶俐, 主编. 循证药学[M]. 北京: 高等教育出版社, 2025: 129-138.

8.L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research[J]. Ann Intern Med, 1987, 107(2): 224-233. DOI: 10.7326/0003-4819-107-2-224.

9.吴昀效, 颜济南, 聂晓璐, 等. 《中国药物流行病学研究方法学指南（第2版）》及其系列解读（1）: 概述[J]. 药物流行病学杂志, 2025, 34(1): 2-11. [Wu YX, Yan JN, Nie XL, et al. Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (1): an overview[J]. Chinese Journal of Pharmacoepidemiology, 2025, 34(1): 2-11.] DOI: 10.12173/j.issn.1004-5511.202412131.

10.Cochrane A, Editor C. Effectiveness and efficiency: random reflections on health services[M]. London: Nuffield Provincial Hospitals Trust, 1972: 2-7.

11.Cochrane A. A critical review, with particular reference to the medical profession. In Medicines for the year 2000[M]. London: Office of Health Economics, 1979: 1-11.

12.Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction[J]. Am J Cardiol, 1983, 52(6): 32C-36C. DOI: 10.1016/0002-9149(83)90629-X.

13.李幼平, 主编. 循证医学[M]. 北京: 人民卫生出版社, 2014: 56-58.

14.Li T, Higgins JPT, Deeks JJ. Chapter 5: Collecting data[EB/OL]. (2019-10) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter05 colonlinepdfv65.

15.郑卿勇, 徐彩花, 周泳佳, 等. 《药物流行病学研究方法学指南(第2版)》系列解读(10): 质量评估工具介绍与案例分析 [J]. 药物流行病学杂志, 2025, 34(10): 1113-1126. [Zheng QY, Xu CH, Zhou YJ, et al. Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (10): an overview and case study of quality assessment tools[J]. Chinese Journal of Pharmacoepidemiology, 2025, 34(10): 1113-1126.] DOI: 10.12173/j.issn.1005-0698. 202509141.

16.Higgins JPT, Li T, Deeks JJ. Chapter 6: Choosing effect measures and computing estimates of effect[EB/OL]. (2023-08) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter06effonlinepdfv65.

17.Deeks JJ, Higgins JPT, Altman DG, et al. Chapter 10: Analysing data and undertaking Meta-analyses[EB/OL]. (2024-11) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter10metonlinepdfv65.

18.Deeks JJ, Bossuyt PM. Chapter 2: Evaluating medical tests[EB/OL]. (2023-07) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook-systematic-reviews-diagnostic-test-accuracy/chapter-pdfs-cochrane-handbook-systematic-reviews-diagnostic-test-accuracy-v20/2-evaluating-diagnostic-tests.

19.Deeks JY, Bossuyt PM, Leeflang MM, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy. 1st edition[EB/OL]. (2023-07) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook-systematic-reviews-diagnostic-test-accuracy/chapter-pdfs-cochrane-handbook-systematic-reviews-diagnostic-test-accuracy-v20.

20.陆瑶, 杨秋玉, 刘雅菲, 等. 如何制作诊断试验准确性比较的系统评价与Meta分析[J]. 中国循证医学杂志, 2022, 22(11): 1339-1347. [Lu Y, Yang QY, Liu YF, et al. How to conduct a systematic review and Meta-analysis of comparative diagnostic test accuracy[J]. Chinese Journal of Evidence-Based Medicine, 2022, 22(11): 1339-1347.] DOI: 10.7507/1672-2531.202206024.

21.杨楠, 邓围，陈耀龙, 等. GRADE在预后研究系统评价中应用的原理、方法及挑战[J]. 中国循证医学杂志, 2015, 15(9): 1112-1116. [Yang N, Deng W, Chen YL, et al. Rationales, methods and challenges of using GRADE in systematic review of prognostic studies[J]. Chinese Journal of Evidence-Based Medicine, 2015, 15(9): 1112-1116.] DOI: 10.7507/1672-2531.20150184.

22.Flemming K, Booth A, Garside R, et al. Qualitative evidence synthesis for complex interventions and guideline development: clarification of the purpose, designs and relevant methods[J]. BMJ Glob Health, 2019, 4(Suppl 1): e000882. DOI: 10.1136/bmjgh-2018-000882.

23.Noyes J, Booth A, Cargo M, et al. Chapter 21: Qualitative evidence[EB/OL]. (2019-10) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter21qalonlinepdfv65.

24.Booth A, Noyes J, Flemming K, et al. Structured methodology review identified seven (RETREAT) criteria for selecting qualitative evidence synthesis approaches[J]. J Clin Epidemiol, 2018, 99: 41-52. DOI: 10.1016/j.jclinepi.2018.03.003.

25.Lin CY, Lin WH, Shu BC. A brief introduction to mixed methods systematic review (MMSR)[J]. Hu Li Za Zhi, 2023, 70(3):75-84. DOI: 10.6224/JN.202306_70(3).10.

26.Stern C, Lizarondo L, Carrier J, et al. Methodological guidance for the conduct of mixed methods systematic reviews[J]. JBI Evid Implement, 2021, 19(2):120-129. DOI: 10.1097/XEB.0000000000000282.

27.陈红丽, 丁晓彤, 王青, 等. 混合方法研究系统评价的方法学及应用进展[J]. 中华护理杂志, 2024, 59(21): 2665-2671. [Chen HL, Ding XT, Wang Q, et al. Methodological and application progress of systematic reviews of mixed methods research[J]. Chinese Journal of Nursing, 2024, 59(21): 2665-2671.] DOI: 10.3761/j.issn.0254-1769.2024.21.016.

28.Chaimani A, Caldwell D, Li T, et al. Chapter 11: Undertaking network Meta-analyses[EB/OL]. (2019-10) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter11nmaonlinepdfv65.

29.Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network Meta-analysis[J]. Lancet, 2018, 391(10128): 1357-1366. DOI: 10.1016/S0140-6736(17)32802-7.

30.Caldwell DM, Dias S, Welton NJ. Extending treatment networks in health technology assessment: how far should we go?[J]. Value Health, 2015, 18(5): 673-681. DOI: 10.1016/j.jval.2015.03.1792.

31.李伦, 田金徽, 姚亮, 等. 网状Meta分析的统计学基础、假设和证据质量评估[J]. 循证医学, 2015, 15(3): 180-183. [Li L, Tian JH, Yao L, et al. The classification, statistical methods, assumption and evidence quality assessment of network Meta-analysis[J]. Journal of Evidence-Based Medicine, 2015, 15(3): 180-183.] DOI: 10.3969/j.issn.1671-5144.2015.03.015.

32.刘凤琪, 杨智荣, 武珊珊, 等. 效应修饰作用分析方法与案例解析系列（二）: 网状Meta分析中的效应修饰[J]. 中华流行病学杂志, 2024, 45(2): 273-278. [Liu FQ, Yang ZR, Wu SS, et al. Analysis methods and case analysis of effect modification (2): effect modification in network Meta-analysis[J]. Chinese Journal of Epidemiology, 2024, 45(2): 273-278.] DOI: 10.3760/cma.j.cn112338-20230824-00094.

33.郑卿勇, 李腾飞, 许建国, 等. 网状Meta分析原理与主流软件包介绍[J]. 中国循证医学杂志, 2025, 25(6): 715-723. [Zheng QY, Li TF, Xu JG, et al. Principles of network Meta-analysis and applications of mainstream software packages[J]. Chinese Journal of Evidence-Based Medicine, 2025, 25(6): 715-723.] DOI: 10.7507/1672-2531.202407073.

34.Pitre T, Abdali D, Chaudhuri D, et al. Corticosteroids in community-acquired bacterial pneumonia: a systematic review, pairwise and dose-response Meta-analysis[J]. J Gen Intern Med, 2023, 38(11): 2593-2606. DOI: 10.1007/s11606-023-08203-6.

35.郭鹏, 周权, 谷万杰, 等. 剂量-反应Meta分析报告规范G-Dose Checklist的解读[J]. 中国循证医学杂志, 2017, 17(6): 736-741. [Guo P, Zhou Q, Gu WJ, et al. Interpretation of reporting guideline for dose-response Meta-analysis-G-Dose Checklist[J]. Chinese Journal of Evidence-Based Medicine, 2017, 17(6): 736-741.] DOI: 10.7507/1672-2531.201612086.

36.Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data[J]. Epidemiology, 1993, 4(3): 218-228. DOI: 10.1097/00001648-199305000-00005.

37.Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to Meta-analysis[J]. Am J Epidemiol, 1992, 135(11): 1301-1309. DOI: 10.1093/oxfordjournals.aje.a116237.

38.Shim SR, Lee J. Dose-response Meta-analysis: application and practice using the R software[J]. Epidemiol Health, 2019, 41: e2019006. DOI: 10.4178/epih.e2019006.

39.Zhang C, Jia P, Yu L, et al. Introduction to methodology of dose-response Meta-analysis for binary outcome: with application on software[J]. J Evid Based Med, 2018, 11(2): 125-129. DOI: 10.1111/jebm.12267.

40.Xu C, Doi SAR. The robust error Meta-regression method for dose-response Meta-analysis[J]. Int J Evid Based Healthc, 2018, 16(3): 138-144. DOI: 10.1097/XEB.0000000000000132.

41.蒋青青, 王世琦, 黄申, 等. 剂量反应Meta分析中常见的统计学问题[J]. 数理医药学杂志, 2023, 36(2): 81-87. [Jiang QQ, Wang SQ, Huang S, et al. Common statistical problems in dose-response Meta-analysis[J]. Journal of Mathematical Medicine, 2023, 36(2): 81-87.] DOI: 10.12173/j.issn.1004-5511. 202212019.

42.Tierney JF, Stewart LA, Clarke M. Chapter 26: Individual participant data[EB/OL]. (2019-10) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter26ipdonlinepdfv65.

43.Nagendran M, Russell JA, Walley KR, et al. Vasopressin in septic shock: an individual patient data Meta-analysis of randomised controlled trials[J]. Intensive Care Med, 2019, 45(6): 844-855. DOI: 10.1007/s00134-019-05620-2.

44.Huang Y, Tang J, Tam WW, et al. Comparing the overall result and interaction in aggregate data Meta-analysis and individual patient data Meta-analysis[J]. Medicine (Baltimore), 2016, 95(14): e3312. DOI: 10.1097/MD.0000000000003312.

45.Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference?[J]. Lancet, 1993, 341(8842): 418-422. DOI: 10.1016/0140-6736(93)93004-K.

46.Simmonds MC, Higgins JP, Stewart LA, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice[J]. Clin Trials, 2005, 2(3): 209-217. DOI: 10.1191/1740774505cn087oa.

47.Spence GT, Steinsaltz D, Fanshawe TR. A Bayesian approach to sequential Meta-analysis[J]. Stat Med, 2016, 35(29): 5356-5375. DOI: 10.1002/sim.7052.

48.Van der Tweel I, Bollen C. Sequential Meta-analysis: an efficient decision-making tool[J]. Clin Trials, 2010, 7(2): 136-146. DOI: 10.1177/1740774509360994.

49.Bolland MJ, Grey A, Gamble GD, et al. Vitamin D supplementation and falls: a trial sequential Meta-analysis[J]. Lancet Diabetes Endocrinol, 2014, 2(7): 573-580. DOI: 10.1016/S2213-8587(14)70068-3.

50.翁鸿, 武珊珊, 张永刚, 等. 序贯Meta分析方法学简介[J]. 中国循证医学杂志, 2016, 16(10): 1216-1220. [Weng H, Wu SS, Zhang YG, et al. Brief introduction of methodology of sequential Meta-analysis[J]. Chinese Journal of Evidence-Based Medicine, 2016, 16(10): 1216-1220.] DOI: 10.7507/1672- 2531.20160184.

51.Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative Meta-analysis[J]. J Clin Epidemiol, 2008, 61(1): 64-75. DOI: 10.1016/j.jclinepi.2007.03.013.

52.Higgins JP, Whitehead A, Simmonds M. Sequential methods for random-effects Meta-analysis[J]. Stat Med, 2011, 30(9): 903-921. DOI: 10.1002/sim.4088.

53.Watt CA, Kennedy JE. Options for prospective Meta-analysis and introduction of registration-based prospective Meta-analysis[J]. Front Psychol, 2016, 7: 2030. DOI: 10.3389/fpsyg.2016.02030.

54.Seidler AL, Hunter KE, Cheyne S, et al. A guide to prospective Meta-analysis[J]. BMJ, 2019, 367: l5342. DOI: 10.1136/bmj.l5342.

55.Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective Meta-analysis of data from 90,056 participants in 14 randomised trials of statins[J]. Lancet, 2005, 366(9493): 1267-1278. DOI: 10.1016/S0140-6736(05)67394-1.

56.Shojania KG, Sampson M, Ansari MT, et al. How quickly do systematic reviews go out of date? a survival analysis[J]. Ann Intern Med, 2007, 147(4): 224-233. DOI: 10.7326/0003-4819-147-4-200708210-00179.

57.Cumpston M, Flemyng E. Chapter IV: Updating a review[EB/OL]. (2023-08) [2025-12-26]. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/PDF/v6.5/chapter-ivonlinepdfv65.

58.Smith GD, Ho K. Systematic reviews: when should they be updated?[J]. J Clin Nurs, 2023, 32(9-10): e17-e18. DOI: 10.1111/jocn.16547.

59.Garner P, Hopewell S, Chandler J, et al. When and how to update systematic reviews: consensus and checklist[J]. BMJ, 2016, 354: i3507. DOI: 10.1136/bmj.i3507.

60.Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. Introduction-the why, what, when, and how[J]. J Clin Epidemiol, 2017, 91: 23-30. DOI: 10.1016/j.jclinepi.2017.08.010.

61.Augustin Y, Staines HM, Velavan TP, et al. Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews[J]. Br Med Bull, 2023, 147(1): 31-49. DOI: 10.1093/bmb/ldac037.

62.Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews: 2. Combining human and machine effort[J]. J Clin Epidemiol, 2017, 91: 31-37. DOI: 10.1016/j.jclinepi.2017. 08.011.

63.Schmidt L, Sinyor M, Webb RT, et al. A narrative review of recent tools and innovations toward automating living systematic reviews and evidence syntheses[J]. Z Evid Fortbild Qual Gesundhwes, 2023, 181: 65-75. DOI: 10.1016/j.zefq.2023.06.007.

64.Khan MA, Ayub U, Naqvi S, et al. Collaborative large language models for automated data extraction in living systematic reviews[J/OL]. medRxiv, 2025: 2025-02-13. DOI: 10.1101/2024.09.20. 24314108.

65.Fuller-Tyszkiewicz M, Jones A, Vasa R, et al. Artificial intelligence software to accelerate screening for living systematic reviews[J/OL]. Clin Child Fam Psychol Rev, 2025: 2025-04-18. DOI: 10.1007/s10567-025-00519-5.

66.Peters MDJ, Godfrey C, McInerney P, et al. JBI manual for evidence synthesis[EB/OL]. (2024-03-27) [2025-12-26]. https://jbi-global-wiki.refined.site/space/MANUAL/4685837/JBI+Manual+for+Evidence+Synthesis.

67.刘晏利, 吴才志, 王浙, 等. JBI范围综述执行流程简介 [J]. 中国循证医学杂志, 2024, 24(8): 986-992. [Liu YL, Wu CZ, Wang Z, et al. An introduction of the JBI scoping review execution process[J]. Chinese Journal of Evidence-Based Medicine, 2024, 24(8): 986-992.] DOI: 10.7507/1672-2531.202311060.

68.Peters MD, Godfrey CM, Khalil H, et al. Guidance for conducting systematic scoping reviews[J]. Int J Evid Based Healthc, 2015, 13(3): 141-146. DOI: 10.1097/XEB.0000000000000050.

69.Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology[J]. Implement Sci, 2010, 5: 69. DOI: 10.1186/1748-5908-5-69.

70.David C, Elizalde-Hernández A, Barboza AS, et al. Cannabidiol in dentistry: a scoping review[J]. Dent J (Basel), 2022, 10(10): 193. DOI: 10.3390/dj10100193.

71.Munn Z, Peters M, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach[J]. BMC Med Res Methodol, 2018, 18(1): 143. DOI: 10.1186/s12874-018-0611-x.

72.Hamel C, Michaud A, Thuku M, et al. Defining rapid reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews[J]. J Clin Epidemiol, 2021, 129: 74-85. DOI: 10.1016/j.jclinepi.2020.09.041.

73.李苗苗, 张乐, 吴雪, 等. 医学研究领域快速综述实施和报告标准介绍及应用分析[J]. 中国中西医结合杂志, 2024, 44(11): 1320-1329. [Li MM, Zhang L, Wu X, et al. Introduction and application of standards for conducting and reporting rapid reviews in healthcare research[J]. Journal of Integrated Traditional and Western Medicine, 2024, 44(11): 1320-1329.] DOI: 10.7661/j.cjim.20240625.135.

74.Harker J, Kleijnen J. What is a rapid review? a methodological exploration of rapid reviews in health technology assessments[J]. Int J Evid Based Healthc, 2012, 10(4): 397-410. DOI: 10.1111/j.1744-1609.2012.00290.x.

75.Garritty C, Hamel C, Trivella M, et al. Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness[J]. BMJ, 2024, 384: e76335. DOI: 10.1136/bmj-2023-076335.

76.Garritty C, Gartlehner G, Nussbaumer-Streit B, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews[J]. J Clin Epidemiol, 2021, 130: 13-22. DOI: 10.1016/j.jclinepi.2020.10.007.

77.李苗苗, 吴雪, 景城阳, 等. 快速综述在医学研究领域应用现状的文献计量学分析[J]. 中国全科医学, 2024, 27(33): 4215-4224. [Li MM, Wu X, Jing CY, et al. The application of rapid review in the field of medical research: a bibliometric analysis[J]. Chinese General Practice, 2024, 27(33): 4215-4224.] DOI: 10.12114/j.issn.1007-9572.2023.0358.

78.Tóth B, Berek L, Gulácsi L, et al. Automation of systematic reviews of biomedical literature: a scoping review of studies indexed in PubMed[J]. Syst Rev, 2024, 13(1): 174. DOI: 10.1186/s13643-024-02592-3.

79.郑卿勇, 周泳佳, 张梦君, 等. 人工智能推动系统评价与Meta分析自动化工具发展[J]. 中国循证医学杂志, 2025, 25(11): 1340-1349. [Zheng QY, Zhou YJ, Zhang MJ, et al. Artificial intelligence promotes the development of automated tools for systematic reviews[J]. Chinese Journal of Evidence-Based Medicine, 2025, 25(11): 1340-1349.] DOI: 10.7507/1672-2531.202501115.

80.郭玉杰, 张雪芹, 孙文宇, 等. 自动化文献筛选工具在系统评价中的应用[J]. 协和医学杂志, 2024, 15(4): 921-926. [Guo YJ, Zhang XQ, Sun WY, et al. Application of automated literature screening tools in systematic reviews[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 921-926.] DOI: 10.12290/xhyxzz.2023-0257.

81.Noel-Storr A, Dooley G, Elliott J, et al. An evaluation of Cochrane Crowd found that crowdsourcing produced accurate results in identifying randomized trials[J]. J Clin Epidemiol, 2021, 133: 130-139. DOI: 10.1016/j.jclinepi.2021.01.006.

82.Marshall IJ, Noel-Storr A, Kuiper J, et al. Machine learning for identifying randomized controlled trials: an evaluation and practitioner's guide[J]. Res Synth Methods, 2018, 9(4): 602-614. DOI: 10.1002/jrsm.1287.

83.Thomas J, Brunton J, Graziosi S. EPPI-Reviewer 4.0: software for research synthesis[Z]. London: EPPI-Centre, Social Science Research Unit, Institute of Education, University of London, 2011.

84.Wallace BC, Small K, Brodley CE, et al. Deploying an interactive machine learning system in an evidence-based practice center[C]. Miami, FL: Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium, 2012.

85.Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews[J]. Syst Rev, 2016, 5(1): 210. DOI: 10.1186/s13643-016-0384-4.

86.Howard BE, Phillips J, Tandon A, et al. SWIFT-active screener: accelerated document screening through active learning and integrated recall estimation[J]. Environ Int, 2020, 138: 105623. DOI: 10.1016/j.envint.2020.105623.

87.Przybyła P, Brockmeier AJ, Kontonatsios G, et al. Prioritising references for systematic reviews with RobotAnalyst: a user study[J]. Res Synth Methods, 2018, 9(3): 470-488. DOI: 10.1002/jrsm.1311.

88.Cheng SH, Augustin C, Bethel A, et al. Using machine learning to advance synthesis and use of conservation and  environmental evidence[J]. Conserv Biol, 2018, 32(4): 762-764. DOI: 10.1111/cobi.13117.

89.Rens Van De Schoot JDBR. An open source machine learning framework for efficient and transparent systematic reviews[J]. Nat Mach Intell, 2021, 3: 125-133. DOI: 10.1038/s42256-020-00287-7.

90.Khalil H, Ameen D, Zarnegar A. Tools to support the automation of systematic reviews: a scoping review[J]. J Clin Epidemiol, 2022, 144: 22-42. DOI: 10.1016/j.jclinepi.2021.12.005.

91.Karlsson WK, Ostinelli EG, Zhuang ZA, et al. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network Meta-analysis[J]. BMJ, 2024, 386: e80107. DOI: 10.1136/bmj-2024-080107.

Popular papers
Last 6 months